Level Four Advisory Services’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
AC
SIMG
PCH
Level Four Advisory Services's SUPN Position: Q2 2023 in Review
Level Four Advisory Services sold out of Supernus Pharmaceuticals (SUPN) in Q2 2023, closing a stake of 21,011 shares — an estimated $761K sold.
Level Four Advisory Services first reported a position in SUPN in Q4 2021 and held it in 6 quarters. The position peaked at $932K in Q3 2022. 249 funds tracked by Wall St. Rank hold SUPN as of Q2 2023.
- Level Four Advisory Services reported no remaining Supernus Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- Level Four Advisory Services sold 21,011 Supernus Pharmaceuticals shares in Q2 2023, an estimated $761K.
- Level Four Advisory Services first reported a position in Supernus Pharmaceuticals in Q4 2021 and held it in 6 quarters.
- Level Four Advisory Services's Supernus Pharmaceuticals position peaked at $932K in Q3 2022.
- 249 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2023.
Based on Level Four Advisory Services's 13F filing for Q2 2023, filed 10 Jul 2023.